Last reviewed · How we verify

NCT03451617: AXES

Alpine vs. Xpedition: Evaluation of Stent Delivery System

Status unknown NA Last updated 2 March 2018
What this trial tests

NA trial testing Stent delivery with Xpedition in Percutaneous Coronary Intervention in 500 participants. Status unknown.

Timeline
5 October 2017
Primary endpoint
5 October 2019
5 October 2020

Quick facts

Lead sponsorUniversity of Groningen
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment500
Start date5 October 2017
Primary completion5 October 2019
Estimated completion5 October 2020
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

University of Groningen

Who can join

18 and older, any sex, with Percutaneous Coronary Intervention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate and compare the performance of two stent delivery systems for percutaneous coronary intervention with everolimus-eluting stent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Percutaneous Coronary Intervention

Currently open trials in the same condition.

Other University of Groningen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing